Myopic macular degeneration (MMD) is a serious eye condition that affects people with severe nearsightedness, also known as high myopia. It causes progressive damage to the retina and choroid, leading to vision loss that can be irreversible if untreated1 2. The prevalence of MMD varies worldwide, with higher rates reported in Asian populations, making it a growing public health concern3 2. Early detection and management are crucial to preserving vision and quality of life for affected individuals1 4.
MMD Symptoms and Signs
Myopic macular degeneration is a progressive condition marked by degenerative changes in the retina and choroid, which worsen over time5 . Early symptoms often include mild visual disturbances such as blurred vision6 . As the disease advances, patients may experience central scotomas—blind spots in the central vision—and metamorphopsia, where straight lines appear wavy or distorted5 6. Other symptoms can include floaters and flashes of light (photopsia), which result from retinal changes6 . Functional impairments such as reduced contrast sensitivity also occur, reflecting damage to the macula6 .
The severity of symptoms correlates with the degree of retinal and choroidal degeneration, which can be visualized using imaging techniques like optical coherence tomography (OCT) 76. These symptoms can significantly impair detailed vision and daily activities, especially reading and recognizing faces6 .
Causes of Myopic Macular Degeneration
Myopic macular degeneration primarily results from progressive axial elongation of the eyeball, which causes mechanical stretching and thinning of the retina and choroid2 45. This structural change increases the eye’s vulnerability to atrophic changes, scarring, and abnormal blood vessel growth, such as choroidal neovascularization (CNV), which contribute to vision loss5 6.
Risk Factors
- High Myopia: Defined typically as a refractive error of −5 diopters or more, high myopia is the strongest risk factor for MMD8 . The longer the axial length of the eye, the greater the risk of developing degenerative changes8 .
- Genetic Predisposition: Family history and genetic factors play a significant role in the development of pathological myopia and associated maculopathy9 6.
- Age: The risk of MMD increases with age and the duration of myopia1 .
- Ethnicity: East Asian populations have a higher prevalence of MMD, possibly due to genetic and environmental factors2 3.
- Severity of Myopia: Stronger myopic refractive errors correlate with increased risk of MMD8 .
- Environmental Factors: Prolonged near work and limited outdoor activity during childhood may contribute to myopia progression, indirectly increasing MMD risk6 .
Diagnosing MMD
Diagnosis of myopic macular degeneration involves a comprehensive ophthalmic examination that includes visual acuity testing and detailed retinal imaging4 56. Key diagnostic tools include:
- Visual Acuity Measurement: Assesses the functional status of the macula6 .
- Dilated Fundus Examination: Allows direct visualization of retinal changes such as chorioretinal atrophy, lacquer cracks, and Fuchs’ spots6 .
- Optical Coherence Tomography (OCT): Provides high-resolution cross-sectional images of the retina and choroid, revealing thinning, scarring, or fluid accumulation6 .
- Fluorescein Angiography: Detects abnormal or leaking blood vessels indicative of choroidal neovascularization6 .
These diagnostic methods help differentiate MMD from other macular diseases and guide treatment decisions6 3.
Myopic Macular Degeneration Treatments
Currently, there is no cure for MMD, and treatment focuses on preserving vision and slowing disease progression4 5. Management depends on the presence and severity of complications such as choroidal neovascularization.
Anti-VEGF Injections
Intravitreal injections of anti-vascular endothelial growth factor (anti-VEGF) agents are the first-line therapy for myopic choroidal neovascularization5 . VEGF promotes pathological neovascular growth and vascular leakage, leading to retinal swelling and vision loss5 . Anti-VEGF drugs inhibit this process, reducing leakage and edema5 . Commonly used agents include ranibizumab and aflibercept5 . These injections are performed under topical anesthesia and require pupil dilation to minimize discomfort5 .
Laser Therapy
Laser photocoagulation can be used to treat neovascular lesions in MMD, especially when anti-VEGF therapy is contraindicated or ineffective5 . The procedure involves applying laser burns to abnormal blood vessels to limit bleeding and damage5 . Patients often perceive light flashes during treatment, which is done after pupil dilation and topical anesthesia5 . However, laser therapy has limitations, including recurrence of neovascularization and limited long-term benefit5 .
Photodynamic Therapy (PDT)
Photodynamic therapy is an alternative or adjunctive treatment for choroidal neovascularization in pathological myopia5 . PDT uses a photosensitizing agent activated by laser light to selectively target abnormal vessels5 . While PDT can reduce neovascular activity, its therapeutic effect is generally inferior to anti-VEGF injections and may be reserved for specific cases5 .
“Myopic choroidal neovascularization (CNV) is a serious complication in pathologic myopia that affects central vision. It recurs frequently and is usually bilateral. The long-term prognosis is poor, even if treated.”
— Takashi Ueta, National Center for Global Health and Medicine, Tokyo10
MMD Prevention Strategies
Preventing or slowing myopia progression in childhood is key to reducing the risk of developing MMD later in life6 . Strategies include:
- Specialized Corrective Lenses: Orthokeratology and multifocal lenses can slow axial elongation by modifying peripheral retinal defocus6 .
- Low-Dose Atropine Eye Drops: These have been shown to effectively slow myopia progression in children6 .
- Increased Outdoor Activity: Spending more time outdoors is associated with reduced incidence and progression of myopia6 .
- Behavioral Modifications: The 20-20-20 rule (taking breaks every 20 minutes to look at something 20 feet away for 20 seconds) helps reduce eye strain6 .
- Limiting Prolonged Near Work: Reducing continuous close-up tasks may help control myopia progression6 .
Regular eye examinations facilitate early detection and timely intervention, potentially preserving vision8 6.
Conditions Related to MMD
Myopic macular degeneration is often associated with other ocular complications that contribute to overall visual morbidity. These include:
- Retinal Detachment: High myopia and MMD increase the risk of retinal tears and detachment, which can cause sudden vision loss5 .
- Glaucoma: Myopic eyes have a higher incidence of open-angle glaucoma, a disease that damages the optic nerve5 .
- Cataracts: There is an increased risk of cataract formation in highly myopic eyes5 .
- Myopic Traction Maculopathy: Structural changes in the retina can lead to traction and macular holes, requiring surgical intervention11 10.
Comprehensive ophthalmic monitoring is essential to detect and manage these related conditions5 .
Living With Myopic Macular Degeneration
Living with MMD requires multidisciplinary care that includes medical treatment, vision rehabilitation, and environmental adaptations4 56. Although vision loss may progress, many patients can preserve functional vision with appropriate management6 . Low vision aids and personalized strategies help improve daily functioning and quality of life6 . Optimizing environmental lighting and adhering to prescribed therapies are important for maintaining vision6 . Ophthalmologists and low vision specialists provide tailored rehabilitation plans to support patients6 .
Pathologic myopia is a major cause of low vision and blindness worldwide. Its social and economic burden has been demonstrated by epidemiological studies.
— Takashi Ueta, National Center for Global Health and Medicine, Tokyo10
Frequently Asked Questions
How is MMD different from age-related macular degeneration (AMD)?
MMD is linked to high myopia and usually affects younger individuals, whereas AMD is age-related and primarily affects those over 50 years old6 12. Both conditions cause macular damage but differ in cause and typical patient age6 .
Can people with MMD continue to drive?
Driving ability depends on visual acuity and visual field status. Mild MMD may not preclude safe driving if vision correction is adequate, but advanced maculopathy can impair critical visual functions necessary for driving safety6 .
Is MMD progression predictable?
The progression of MMD is heterogeneous and influenced by multiple ocular and systemic factors. Regular monitoring is essential to detect changes early and adjust treatment accordingly6 .
Are there any lifestyle changes that can help manage MMD?
While lifestyle changes cannot reverse MMD, increasing outdoor activity and reducing near work during childhood may reduce myopia progression and future risk of MMD6 .
What treatments are available if vision worsens?
Anti-VEGF injections are the main treatment for choroidal neovascularization. Laser therapy and photodynamic therapy are alternatives in select cases. Vision rehabilitation and low vision aids also support quality of life5 6.
